Skip to main content

Table 2 Hematological assessment of the studied groups (n = 120)

From: Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Laboratory investigations Patients without risk factors cryptogenic (A1) (n = 37) Patients with risk factors (A2) (n = 23) Controls (healthy) (n = 60) Test value p-value Post hoc between group A1 and A2
HB (g/dl) Mean ± SD 12.8 ± 1.5 12.3 ± 2.7 12.6 ± 1.8 F = 0.238 0.78 0.97
Range 9.5–16.2 8.2–16.5 9.2–16.1
WBC X 103/μL Mean ± SD 7.94 ± 7.94 8.43 ± 3.3 6.26 ± 2.0 F = 8.87 < 0.001* 0.74
Range 3.77–13.5 4.5–16.75 4.32–10
PLTs X103/μL Mean ± SD 264 ± 78.645 270 ± 101.89 241 ± 92.82 F = 1.21 0.30 0.964
Range 130–446 95–493 493–600
MPV (fl) Mean ± SD 10.6 ± 1.5 10.9 ± 1.6 9.3 ± 1.7 F = 11.81 < 0.001* 0.781
Range 8.5–14.2 8.4–14.5 6.0–12.9
PDW (fl) Mean ± SD 13.6 ± 2.9 13.5 ± 1.9 11.9 ± 1.9 F = 8.75 < 0.001* 0.6124
Range 9.5–22 10.5–16.9 9.4–20.7
L-PCR (%) Mean ± SD 29.4 ± 5.1 26.4 ± 4.9 28.9 ± 6.1 F = 2.14 0.542 0.12
Range 15.4–38.1 19.5–41.9 18.4–47.9
  1. *One-way ANOVA test (F) is statistically significant at level of significance of 95% (p < 0.05). MPV mean platelet volume, PDW platelet distribution width, L-PCR large platelet cell ratio, HB hemoglobin, WBC white blood cells, PLT = platelet, MPV mean platelet volume, PDW platelet distribution width, L-PCR large platelet cell ratio
  2. bold indicates statistically significant relation
  3. italic indicates the type of the test used